Intra-articular sprifermin therapy reduces total knee replacements: accumulated evidence from translational and clinical data von Ladel, C., Daelken, B., Michaelis, M., Guenther, O., Moreau, F., Guehring, H.

Volltext

Long-term efficacy and safety of intra-articular sprifermin in patients with knee osteoarthritis: results from the 5-year forward study von Eckstein, F., Hochberg, M., Kraines, J., Guehring, H., Moreau, F., Ona, V., Bihlet, A.R., Byrjalsen, I., Andersen, J.R., Daelken, B., Guenther, O., Ladel, C., Michaelis, M., Conaghan, P.G.

Volltext

Recombinant immunotoxins and retargeted killer cells: employing engineered antibody fragments for tumor-specific targeting of cytotoxic effectors von WELS, Winfried, BIBURGER, Markus, MÜLLER, Tina, DÄLKEN, Benjamin, GIESÜBEL, Ulrike, TONN, Torsten, UHEREK, Christoph

Volltext

Response letter to the Editor von Conaghan, PG, Guehring, H, Moreau, F, Daelken, B, Ladel, C, Guenther, O, Bihlet, AR, Wirth, W, Eckstein, F, Hochberg, M

Volltext bestellen

The effects of sprifermin on symptoms and structure in a subgroup at risk of progression in the FORWARD knee osteoarthritis trial von Guehring, H, Moreau, F, Daelken, B, Ladel, C, Guenther, O, Bihlet, AR, Wirth, W, Eckstein, F, Hochberg, M, Conaghan, PG

Volltext bestellen

Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study von Eckstein, F, Hochberg, MC, Guehring, H, Moreau, F, Ona, V, Bihlet, AR, Byrjalsen, I, Andersen, JR, Daelken, B, Guenther, O, Ladel, C, Michaelis, M, Conaghan, PG

Volltext bestellen